228 related articles for article (PubMed ID: 34079522)
1. Composite Cardiovascular Outcomes in Patients With Primary Aldosteronism Undergoing Medical Versus Surgical Treatment: A Meta-Analysis.
Huang WC; Chen YY; Lin YH; Chueh JS
Front Endocrinol (Lausanne); 2021; 12():644260. PubMed ID: 34079522
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular outcomes and all-cause mortality in primary aldosteronism after adrenalectomy or mineralocorticoid receptor antagonist treatment: a meta-analysis.
Chen SY; Chen JY; Huang WC; Puar THK; Chin Kek P; Chueh JS; Lin YH; Wu VC; Study Group T
Eur J Endocrinol; 2022 Dec; 187(6):S47-S58. PubMed ID: 36315466
[TBL] [Abstract][Full Text] [Related]
3. New-Onset Atrial Fibrillation in Patients With Primary Aldosteronism Receiving Different Treatment Strategies: Systematic Review and Pooled Analysis of Three Studies.
Tsai CH; Chen YL; Pan CT; Lin YT; Lee PC; Chiu YW; Liao CW; Chen ZW; Chang CC; Chang YY; Hung CS; Lin YH
Front Endocrinol (Lausanne); 2021; 12():646933. PubMed ID: 34108934
[TBL] [Abstract][Full Text] [Related]
4. Incidence of Atrial Fibrillation and Mineralocorticoid Receptor Activity in Patients With Medically and Surgically Treated Primary Aldosteronism.
Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
JAMA Cardiol; 2018 Aug; 3(8):768-774. PubMed ID: 30027227
[TBL] [Abstract][Full Text] [Related]
5. Hypertension outcomes of adrenalectomy in patients with primary aldosteronism: a systematic review and meta-analysis.
Zhou Y; Zhang M; Ke S; Liu L
BMC Endocr Disord; 2017 Oct; 17(1):61. PubMed ID: 28974210
[TBL] [Abstract][Full Text] [Related]
6. Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies.
Marzano L; Colussi G; Sechi LA; Catena C
Am J Hypertens; 2015 Mar; 28(3):312-8. PubMed ID: 25336498
[TBL] [Abstract][Full Text] [Related]
7. Primary Aldosteronism: Cardiovascular Outcomes Pre- and Post-treatment.
Hundemer GL
Curr Cardiol Rep; 2019 Jul; 21(9):93. PubMed ID: 31352525
[TBL] [Abstract][Full Text] [Related]
8. Systematic review of surgery and outcomes in patients with primary aldosteronism.
Muth A; Ragnarsson O; Johannsson G; Wängberg B
Br J Surg; 2015 Mar; 102(4):307-17. PubMed ID: 25605481
[TBL] [Abstract][Full Text] [Related]
9. Systematic review of the clinical outcomes of mineralocorticoid receptor antagonist treatment versus adrenalectomy in patients with primary aldosteronism.
Satoh M; Maruhashi T; Yoshida Y; Shibata H
Hypertens Res; 2019 Jun; 42(6):817-824. PubMed ID: 30948836
[TBL] [Abstract][Full Text] [Related]
10. Long-term mortality and cardiovascular events in patients with unilateral primary aldosteronism after targeted treatments.
Wu VC; Wang SM; Huang KH; Tsai YC; Chan CK; Yang SY; Lin LY; Chang CC; Lu CC; Lin YH; Chen YM; Chueh JS
Eur J Endocrinol; 2021 Dec; 186(2):195-205. PubMed ID: 34851859
[TBL] [Abstract][Full Text] [Related]
11. Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study.
Hundemer GL; Curhan GC; Yozamp N; Wang M; Vaidya A
Lancet Diabetes Endocrinol; 2018 Jan; 6(1):51-59. PubMed ID: 29129576
[TBL] [Abstract][Full Text] [Related]
12. Benefits of Surgical Over Medical Treatment for Unilateral Primary Aldosteronism.
Ahmed S; Hundemer GL
Front Endocrinol (Lausanne); 2022; 13():861581. PubMed ID: 35557845
[TBL] [Abstract][Full Text] [Related]
13. Treatment of primary aldosteronism: Clinical practice guidelines of the Taiwan Society of Aldosteronism.
Tseng CS; Chan CK; Lee HY; Pan CT; Peng KY; Wang SM; Huang KH; Tsai YC; Wu VC; Chueh JS;
J Formos Med Assoc; 2024 Mar; 123 Suppl 2():S125-S134. PubMed ID: 37328332
[TBL] [Abstract][Full Text] [Related]
14. Influence of Different Treatment Strategies on New-Onset Atrial Fibrillation Among Patients With Primary Aldosteronism: A Nationwide Longitudinal Cohort-Based Study.
Pan CT; Liao CW; Tsai CH; Chen ZW; Chen L; Hung CS; Liu YC; Lin PC; Chang CC; Chang YY; Wu VC; Lin YH;
J Am Heart Assoc; 2020 Mar; 9(5):e013699. PubMed ID: 32070205
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular events and all-cause mortality in surgically or medically treated primary aldosteronism: A Meta-analysis.
Jing Y; Liao K; Li R; Yang S; Song Y; He W; Wang K; Yang J; Li Q; Hu J
J Renin Angiotensin Aldosterone Syst; 2021; 22(1):14703203211003781. PubMed ID: 33752505
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular outcomes in patients with primary aldosteronism after treatment.
Catena C; Colussi G; Nadalini E; Chiuch A; Baroselli S; Lapenna R; Sechi LA
Arch Intern Med; 2008 Jan; 168(1):80-5. PubMed ID: 18195199
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Primary Aldosteronism Reduces the Probability of Obstructive Sleep Apnea.
Wang E; Chomsky-Higgins K; Chen Y; Nwaogu I; Seib CD; Shen WT; Duh QY; Suh I
J Surg Res; 2019 Apr; 236():37-43. PubMed ID: 30694777
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic outcomes with surgical and medical management for primary aldosteronism: protocol for a systematic review and meta-analysis.
Rocca A; Gkaniatsa E; Brunese MC; Hessman E; Muth A; Nwaru BI; Ragnarsson O; Bobbio E; Esposito D
BMJ Open; 2023 Jul; 13(7):e072585. PubMed ID: 37518075
[TBL] [Abstract][Full Text] [Related]
19. Outcomes analysis of surgical and medical treatments for patients with primary aldosteronism.
Park KS; Kim JH; Yang YS; Hong AR; Lee DH; Moon MK; Choi SH; Shin CS; Kim SW; Kim SY
Endocr J; 2017 Jun; 64(6):623-632. PubMed ID: 28458337
[TBL] [Abstract][Full Text] [Related]
20. Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism.
Rossi GP; Cesari M; Cuspidi C; Maiolino G; Cicala MV; Bisogni V; Mantero F; Pessina AC
Hypertension; 2013 Jul; 62(1):62-9. PubMed ID: 23648698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
